EcoDrugPlus

Ensembl ID : ENSCVAG00000010761
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSCVAG00000010781
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSCVAG00000022709
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSCVAG00000000443
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSCVAG00000011090
Gene Symbol: -
Cross references: -
280 Possible Orthologues:

Ensembl ID : ENSCVAG00000020975
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSCVAG00000011335
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSCVAG00000011322
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSCVAG00000001194
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSCVAG00000022560
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSCVAG00000019978
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSCVAG00000000256
Gene Symbol: -
Cross references: -
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).